|
1
|
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.
|
Lancet
|
2007
|
7.01
|
|
2
|
Network modulation in the treatment of Parkinson's disease.
|
Brain
|
2006
|
2.52
|
|
3
|
Changes in network activity with the progression of Parkinson's disease.
|
Brain
|
2007
|
2.46
|
|
4
|
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.
|
J Cereb Blood Flow Metab
|
2006
|
2.42
|
|
5
|
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.
|
Proc Natl Acad Sci U S A
|
2007
|
1.98
|
|
6
|
Metabolic brain networks associated with cognitive function in Parkinson's disease.
|
Neuroimage
|
2006
|
1.92
|
|
7
|
Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.
|
J Neurosci
|
2008
|
1.56
|
|
8
|
Assessment of the progression of Parkinson's disease: a metabolic network approach.
|
Lancet Neurol
|
2007
|
1.42
|
|
9
|
Abnormal metabolic networks in atypical parkinsonism.
|
Mov Disord
|
2008
|
1.39
|
|
10
|
Microstructural white matter changes in primary torsion dystonia.
|
Mov Disord
|
2008
|
1.38
|
|
11
|
Imaging essential tremor.
|
Mov Disord
|
2010
|
1.27
|
|
12
|
Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism.
|
J Cereb Blood Flow Metab
|
2006
|
1.26
|
|
13
|
Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.
|
Brain
|
2008
|
1.24
|
|
14
|
Quantification of Parkinson's disease-related network expression with ECD SPECT.
|
Eur J Nucl Med Mol Imaging
|
2006
|
1.24
|
|
15
|
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes.
|
J Nucl Med
|
2009
|
1.20
|
|
16
|
Dopaminergic suppression of brain deactivation responses during sequence learning.
|
J Neurosci
|
2008
|
1.15
|
|
17
|
Abnormal regional brain function in Parkinson's disease: truth or fiction?
|
Neuroimage
|
2008
|
1.12
|
|
18
|
Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET.
|
J Neurosurg
|
2009
|
0.90
|